$HAE News

Haemonetics to Present at Goldman Sachs 47th Annual Global Healthcare Conference

Citigroup Maintains Neutral on Haemonetics, Raises Price Target to $70

Why Haemonetics (HAE) Is Up 14.3% After Earnings Beat And BofA Upgrade And What's Next

Haemonetics (HAE) Stock Is Up, What You Need To Know

Medical Devices & Supplies - Specialty Stocks Q1 Highlights: Haemonetics (NYSE:HAE)

B of A Securities Upgrades Haemonetics (HAE)

Investing in Haemonetics (HAE)? Don't Miss Assessing Its International Revenue Trends

B of A Securities Upgrades Haemonetics to Buy, Raises Price Target to $80

Does Haemonetics (HAE) Have Enduring Growth Potential?

3 Russell 2000 Stocks That Concern Us

3 Small-Cap Stocks We’re Skeptical Of

Is the Options Market Predicting a Spike in Haemonetics Stock?

Barrington Research Maintains Outperform on Haemonetics, Lowers Price Target to $89

Haemonetics Corporation (HAE) Presents at Bank of America Global Healthcare Conference 2026 Transcript

A Look At Haemonetics (HAE) Valuation After Recent Share Price Weakness

HAE Stock Gains on Q4 Earnings & Revenue Beat, Gross Margin Cut

Haemonetics Corporation 2026 Q4 - Results - Earnings Call Presentation

Haemonetics Q4 Earnings Call Highlights

Haemonetics (HAE) Q4 2026 Earnings Transcript

JP Morgan Maintains Neutral on Haemonetics, Lowers Price Target to $62